Free shipping on all orders over $ 500

 About 5 results found for searched term "SF 11" (0.055 seconds)

Cat.No.  Name Target
M1925 LY294002 PI3K
NSC 697286; SF 1101
LY294002 is a highly selective PI3K inhibitor with IC50 values of 0.31, 0.73, 1.06 and 6.60 μM for PI3Kβ, PI3Kα, PI3Kδ and PI3Kγ respectively. LY294002 also inhibits CK2 with an IC50 of 98 nM. LY294002 is a competitive DNA-PK inhibitor that binds reversibly to the kinase domain of DNA-PK with an IC50 of 1.4 μM.
M3007 SF1126 PI3K
SF1126 is the RGDS-conjugated precursor of LY294002 and the first-in-class dual PI3K/BRD4 pan-inhibitor with anti-tumor and anti-angiogenic activities. It also induces apoptosis.
M7289 SF 11 Neuropeptide Receptor
SF 11 is a nPY Y 2 receptor antagonist.
M15095 Recombinant Mouse RANKL (HEK293, N-6His) Cytokines and Growth Factors
Tnfsf11
Recombinant Mouse RANKL/TNFSF11 is a member of the tumor necrosis factor (TNF) cytokine family. Tnfsf11 is involved in a number of fundamental biological processes such as acting as regulator of interactions between T-cells and dendritic cells, the regulation of the T-cell-dependent immune response and enhancing bone-resorption in humoral hypercalcemia of malignancy. It augments the ability of dendritic cells to stimulate naive T-cell proliferation.
M55293 Recombinant Mouse RANKL (E. coli) Cytokines and Growth Factors
TNFSF11
RANKL is a member of the TNF superfamily of ligands and receptors that play an important role in the regulation of specific immunity and bone turnover. Tnfsf11 is involved in many fundamental biological processes, such as acting as a regulator of interactions between T cells and dendritic cells, regulating T cell-dependent immune responses and enhancing bone resorption in malignant humoral hypercalcemia. It enhances the ability of dendritic cells to stimulate the proliferation of naive T cells.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.